[dt_sc_one_third id=”column_data” column_type=”None” first]
[/dt_sc_one_third][dt_sc_hr_medium /][dt_sc_one_third id=”column_data” column_type=”None” first]
[/dt_sc_one_third][dt_sc_two_third id=”column_data” column_type=”None” column_css=”meet_drKhan” ]
Dr. Khan has been international recognised as a World Expert in Hyperparathyroidism
Aliya Khan is a Clinical Professor of Medicine, Divisions of Endocrinology and
Metabolism and Geriatrics at McMaster University and Director of the Calcium
Disorders Clinic at McMaster University Medical Centre. She is also the Director of
the Fellowship program in Metabolic Bone Disease at McMaster University.
She graduated from the University of Ottawa Medical School with Honors. She
trained in Internal Medicine, Geriatric Medicine and Endocrinology at the University
of Toronto and also completed a research fellowship in Calcium and Metabolic Bone
disorders at the University of Toronto.
She has published over 200 scientific papers on osteoporosis and parathyroid
disease as well as numerous book chapters. She is the Editor of the Handbook of
Parathyroid Diseases. She co-chaired the International Workshops on Primary
Hyperparathyroidism as well as the International Workshop on
Hypoparathyroidism. Dr. Khan is the Chair of the Rapid Response Committee of
Osteoporosis Canada; a Scientific Advisor of the International Osteoporosis
Foundation and Chair of the International Osteonecrosis of the Jaw Task Force.
Dr. Khan has received numerous awards including the International Clinician
Instructor of the Year 2011 award by the International Society of Clinical
Densitometry. The Queen’s Diamond Jubilee Medal for 2012 for excellence in clinical
care, research, and teaching as well as the International Hypoparathyroidism Award
for 2014 and the International Osteoporosis Foundation award for publishing
excellence in 2017.
[/dt_sc_one_half][dt_sc_one_half ][dt_sc_h3 class=””]Bone Research and Education Centre[/dt_sc_h3]
The BREC is a Centre of Excellence in the Diagnosis and Management of Metabolic Bone Disease, Calcium and Parathyroid Disorders.
The goals and objectives of the BREC are:
- To deliver state of the art clinical care to people with metabolic bone disease or calcium and parathyroid disorders.
- Advance clinical research in understanding the mechanisms for disease development and development of new drug therapy
- Disseminate knowledge providing physicians both generalists and specialists with the tools to diagnose and treat bone diseases and calcium disorders.
- Provide an onsite multi-media learning centre for patients and physician
The Center will provide clinical care with on site diagnosis and management of complex metabolic bone diseases, calcium and parathyroid diseases. Clinical research will focus on developing new therapies for osteoporosis, renal osteodystrophy and parathyroid diseases. Bone biopsies will continue to be completed at Halton Healthcare Services. Bone Density studies will be completed on site.
Text on the button [/dt_sc_one_half][dt_sc_hr_medium /][dt_sc_one_third first][dt_sc_post id=”1894″ read_more_text=”Read More” excerpt_length=”15″ /][/dt_sc_one_third][dt_sc_one_third ][dt_sc_post id=”246″ read_more_text=”Read More” excerpt_length=”15″ /][/dt_sc_one_third][dt_sc_one_third ][dt_sc_post id=”250″ read_more_text=”Read More” excerpt_length=”15″ /][/dt_sc_one_third]